Home Cart Sign in  
Chemical Structure| 2323027-38-7 Chemical Structure| 2323027-38-7

Structure of Ceapin-A7
CAS No.: 2323027-38-7

Chemical Structure| 2323027-38-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ceapin-A7 is a selective blocker of ATF6α signaling in response to ER stress with IC50 of 0.59 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ceapin-A7

CAS No. :2323027-38-7
Formula : C20H12F6N4O3
M.W : 470.32
SMILES Code : O=C(C1=NOC(C2=CC=CO2)=C1)NC3=CN(CC4=CC=C(C(F)(F)F)C=C4C(F)(F)F)N=C3
MDL No. :MFCD31567506
InChI Key :UJTDYOXTXGBHEG-UHFFFAOYSA-N
Pubchem ID :154730128

Safety of Ceapin-A7

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 cells 6 µM 24 to 72 hours Inhibited ATF6 cleavage, reduced virus titer mSphere. 2021 Jun 30;6(3):e0036121.
Human chondrocytes 500 nM 24 hours Inhibited ATF6 activation and reduced FGF2 expression iScience. 2021 Jun 28;24(7):102791.
PBMCs 6 µM 1 hour Inhibit ATF6 signaling pathway and reduce the expression of ATF6α Mol Med. 2024 Nov 29;30(1):237.
RA FLSs 1, 2, or 5 µM 24 hours Inhibited BIRC3 expression Front Immunol. 2022 Oct 10;13:965708.
CD4+T cells 6 µM 1 hour Inhibit ATF6 signaling pathway and reduce the differentiation of Th17 cells Mol Med. 2024 Nov 29;30(1):237.
Bovine pulmonary artery endothelial cells (BPAEC) 20 µM 16, 20, 24, 36, 48 hours To evaluate the effects of Ceapin-A7 on ATF6 activation and Cofilin phosphorylation. Ceapin-A7 reduced ATF6 activation and Cofilin phosphorylation. Cell Signal. 2022 Nov;99:110432.
Bovine pulmonary artery endothelial cells (BPAEC) 15 µM 24 hours To evaluate the effects of Ceapin-A7 on LPS-induced endothelial barrier dysfunction. Ceapin-A7 enhanced LPS-induced VE-cadherin internalization and barrier dysfunction. Cell Signal. 2022 Nov;99:110432.
Bovine pulmonary artery endothelial cells (BPAEC) 10, 15, 20 µM 24 hours To evaluate the effects of Ceapin-A7 on ATF6 activation and Cofilin phosphorylation. Ceapin-A7 decreased ATF6 activation and Cofilin phosphorylation. Cell Signal. 2022 Nov;99:110432.
Bovine pulmonary artery endothelial cells (BPAEC) 1–150 µM 24 hours and 48 hours To evaluate the effects of Ceapin-A7 on cell viability. Moderate doses (1–25 μM) were non-toxic, while higher doses (50–150 μM) reduced cell viability. Cell Signal. 2022 Nov;99:110432.
786-O cells 20 µM 5 hours Inhibited ATF6 activation, reversed the increased expression of PINK1 and BNIP3 caused by NR3C1 knockdown. J Transl Med. 2023 Oct 8;21(1):701.
ACHN cells 20 µM 5 hours Inhibited ATF6 activation, reversed the increased expression of PINK1 and BNIP3, and the decreased expression of LC3 and increased expression of P62 caused by NR3C1 knockdown. J Transl Med. 2023 Oct 8;21(1):701.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SKG mice Ankylosing spondylitis model Oral administration in drinking water 1 mM Continuous administration until the end of the experiment Reduced the number of vessels and osteophytes, inhibited angiogenesis-osteogenesis coupling iScience. 2021 Jun 28;24(7):102791.
DBA/1J mice Collagen-induced arthritis (CIA) model Intraperitoneal injection 10 mg/kg Three times per week from days 22 to days 45 Reduced arthritis severity and bone erosion Front Immunol. 2022 Oct 10;13:965708.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.63mL

2.13mL

1.06mL

21.26mL

4.25mL

2.13mL

References

 

Historical Records

Categories